» Articles » PMID: 20123319

Impaired Kidney Function and Atrial Fibrillation in Elderly Subjects

Overview
Journal J Card Fail
Date 2010 Feb 4
PMID 20123319
Citations 17
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Impaired kidney function is associated with increased risk for cardiovascular events. We evaluated whether kidney function is associated with atrial fibrillation (AF) risk in elderly persons.

Methods And Results: Subjects were participants in the Cardiovascular Health Study (CHS), a population-based cohort of ambulatory elderly. Measures of kidney function were cystatin C and creatinine-based estimated glomerular filtration rate (eGFR). Among the 4663 participants, 342 (7%) had AF at baseline and 579 (13%) developed incident AF during follow-up (mean 7.4 years). In unadjusted analyses, cystatin C quartiles were strongly associated with prevalent AF with a nearly 3-fold odds in the highest quartile compared with the lowest (HR=1.19, 95% CI [0.80-1.76] in quartile 2; HR=2.00, 95% CI [1.38-2.88] in quartile 3; and HR=2.87, 95% CI [2.03-4.07] in quartile 4). This increased risk for prevalent AF remained significant after multivariate adjustment. The risk for incident AF increased across cystatin C quartiles in the unadjusted analysis (HR=1.37, 95% CI [1.07-1.75] in quartile 2; HR=1.43, 95% CI [1.11-1.84] in quartile 3; and HR=1.88, 95% CI [1.47-2.41] in quartile 4); however, after multivariate adjustment, these findings were no longer significant. An estimated GFR <60 mL.min.1.73m(2) was associated with prevalent and incident AF in unadjusted, but not multivariate analyses.

Conclusions: Impaired kidney function, as measured by cystatin C, is an independent marker of prevalent AF; however, neither cystatin C nor eGFR are predictors of incident AF.

Citing Articles

Kidney function, uric acid, and risk of atrial fibrillation: experience from the AMORIS cohort.

Ding M, Schmidt-Mende K, Carrero J, Engstrom G, Hammar N, Modig K BMC Cardiovasc Disord. 2024; 24(1):581.

PMID: 39438792 PMC: 11494868. DOI: 10.1186/s12872-024-04236-9.


Atrial fibrillation: primary prevention, secondary prevention, and prevention of thromboembolic complications: part 1.

Trohman R, Huang H, Sharma P Front Cardiovasc Med. 2023; 10:1060030.

PMID: 37396596 PMC: 10311453. DOI: 10.3389/fcvm.2023.1060030.


Association of chronic kidney disease with all-cause mortality in patients hospitalized for atrial fibrillation and impact of clinical and socioeconomic factors on this association.

Bao M, Shu G, Chen C, Chen Y, Wang J, Wang Y Front Cardiovasc Med. 2022; 9:945106.

PMID: 36505361 PMC: 9729356. DOI: 10.3389/fcvm.2022.945106.


Bidirectional Association Between Kidney Function and Atrial Fibrillation: A Population-Based Cohort Study.

van der Burgh A, Geurts S, Ikram M, Hoorn E, Kavousi M, Chaker L J Am Heart Assoc. 2022; 11(10):e025303.

PMID: 35579615 PMC: 9238570. DOI: 10.1161/JAHA.122.025303.


Fluctuating renal function and the risk of incident atrial fibrillation: a nationwide population-based study.

Kwon S, Lee S, Choi E, Han K, Yang S, Lee S Sci Rep. 2019; 9(1):18055.

PMID: 31792292 PMC: 6889358. DOI: 10.1038/s41598-019-54528-w.


References
1.
Rocha R, Stier Jr C . Pathophysiological effects of aldosterone in cardiovascular tissues. Trends Endocrinol Metab. 2001; 12(7):308-14. DOI: 10.1016/s1043-2760(01)00432-5. View

2.
Zucker I, Gorman A, Cornish K, Lang M . Imparied atrial receptor modulation or renal nerve activity in dogs with chronic volume overload. Cardiovasc Res. 1985; 19(7):411-8. DOI: 10.1093/cvr/19.7.411. View

3.
Fried L, Borhani N, Enright P, Furberg C, Gardin J, Kronmal R . The Cardiovascular Health Study: design and rationale. Ann Epidemiol. 1991; 1(3):263-76. DOI: 10.1016/1047-2797(91)90005-w. View

4.
Wachtell K, Lehto M, Gerdts E, Olsen M, Hornestam B, Dahlof B . Angiotensin II receptor blockade reduces new-onset atrial fibrillation and subsequent stroke compared to atenolol: the Losartan Intervention For End Point Reduction in Hypertension (LIFE) study. J Am Coll Cardiol. 2005; 45(5):712-9. DOI: 10.1016/j.jacc.2004.10.068. View

5.
Schrier R . Body fluid volume regulation in health and disease: a unifying hypothesis. Ann Intern Med. 1990; 113(2):155-9. DOI: 10.7326/0003-4819-113-2-155. View